Search hospitals > Ohio > Columbus
Aventiv Research, Inc.
Claim this profileColumbus, Ohio 43213
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Coronavirus
Conducts research for Osteoarthritis
Conducts research for COVID-19
225 reported clinical trials
5 medical researchers
Summary
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, Type 2 Diabetes, Coronavirus, Osteoarthritis, COVID-19 and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 197 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.Top PIs
Andrew W. PippasJohn B Amos Cancer Center7 years of reported clinical research
Studies Cancer
Studies Tumors
18 reported clinical trials
52 drugs studied
Samir Arora, MDAventiv Research Inc2 years of reported clinical research
Studies Type 2 Diabetes
Studies Osteoarthritis
15 reported clinical trials
18 drugs studied
Sridhar Guduri, MDAventiv Research Inc3 years of reported clinical research
Studies Allergy
Studies Peanut Allergy
14 reported clinical trials
20 drugs studied
Kenneth R BorenAventiv Research3 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
4 reported clinical trials
6 drugs studied
Clinical Trials running at Aventiv Research, Inc.
Obesity
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Diabetes
Fatty Liver Disease
Coronavirus
Liver Disease
Chronic Kidney Disease
Cardiovascular Disease
Shingles
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
Tirzepatide
for Obesity
This trial is testing a weight-loss medication called tirzepatide in teenagers who are overweight or obese and have other health problems related to their weight. The study will last about two years and involve multiple visits. Tirzepatide is effective in treating obesity in patients with and without diabetes.
Recruiting1 award Phase 33 criteria
Tirzepatide
for Obesity
This trial is testing tirzepatide, a medication that helps control blood sugar and reduce appetite, to see if it can lower health problems and death rates in adults who are very overweight. Tirzepatide was developed by Eli Lilly to improve blood sugar control in adults with type 2 diabetes.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Aventiv Research, Inc.?
Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Diabetes, Type 2 Diabetes, Coronavirus, Osteoarthritis, COVID-19 and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 197 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.